Cargando…

Congenital adrenal hyperplasia

Congenital adrenal hyperplasia consists of a heterogenous group of inherited disorders due to enzymatic defects in the biosynthetic pathway of cortisol and/or aldosterone. This results in glucocorticoid deficiency, mineralocorticoid deficiency, and androgen excess. 95% of CAH cases are due to 21-hyd...

Descripción completa

Detalles Bibliográficos
Autores principales: Dessinioti, Cleo, Katsambas, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329455/
https://www.ncbi.nlm.nih.gov/pubmed/22523607
http://dx.doi.org/10.4161/derm.1.2.7818
_version_ 1782229843774013440
author Dessinioti, Cleo
Katsambas, Andreas
author_facet Dessinioti, Cleo
Katsambas, Andreas
author_sort Dessinioti, Cleo
collection PubMed
description Congenital adrenal hyperplasia consists of a heterogenous group of inherited disorders due to enzymatic defects in the biosynthetic pathway of cortisol and/or aldosterone. This results in glucocorticoid deficiency, mineralocorticoid deficiency, and androgen excess. 95% of CAH cases are due to 21-hydroxylase deficiency. Clinical forms range from the severe, classical CAH associated with complete loss of enzyme function, to milder, non-classical forms (NCAH). Androgen excess affects the pilosebaceous unit, causing cutaneous manifestations such as acne, androgenetic alopecia and hirsutism. Clinical differential diagnosis between NCAH and polycystic ovary syndrome may be difficult. In this review, the evaluation of patients with suspected CAH, the clinical presentation of CAH forms, with emphasis on the cutaneous manifestations of the disease, and available treatment options, will be discussed.
format Online
Article
Text
id pubmed-3329455
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-33294552012-04-20 Congenital adrenal hyperplasia Dessinioti, Cleo Katsambas, Andreas Dermatoendocrinol Review Congenital adrenal hyperplasia consists of a heterogenous group of inherited disorders due to enzymatic defects in the biosynthetic pathway of cortisol and/or aldosterone. This results in glucocorticoid deficiency, mineralocorticoid deficiency, and androgen excess. 95% of CAH cases are due to 21-hydroxylase deficiency. Clinical forms range from the severe, classical CAH associated with complete loss of enzyme function, to milder, non-classical forms (NCAH). Androgen excess affects the pilosebaceous unit, causing cutaneous manifestations such as acne, androgenetic alopecia and hirsutism. Clinical differential diagnosis between NCAH and polycystic ovary syndrome may be difficult. In this review, the evaluation of patients with suspected CAH, the clinical presentation of CAH forms, with emphasis on the cutaneous manifestations of the disease, and available treatment options, will be discussed. Landes Bioscience 2009 /pmc/articles/PMC3329455/ /pubmed/22523607 http://dx.doi.org/10.4161/derm.1.2.7818 Text en Copyright © 2009 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Review
Dessinioti, Cleo
Katsambas, Andreas
Congenital adrenal hyperplasia
title Congenital adrenal hyperplasia
title_full Congenital adrenal hyperplasia
title_fullStr Congenital adrenal hyperplasia
title_full_unstemmed Congenital adrenal hyperplasia
title_short Congenital adrenal hyperplasia
title_sort congenital adrenal hyperplasia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329455/
https://www.ncbi.nlm.nih.gov/pubmed/22523607
http://dx.doi.org/10.4161/derm.1.2.7818
work_keys_str_mv AT dessinioticleo congenitaladrenalhyperplasia
AT katsambasandreas congenitaladrenalhyperplasia